SARS-CoV-2 Nucleocapsid anticorps (HRP)
-
- Antigène Voir toutes SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N) Anticorps
- SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N)
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp SARS-CoV-2 Nucleocapsid est conjugé à/à la HRP
-
Application
- Western Blotting (WB)
- Purification
- Purified by Protein A.
- Immunogène
- KLH conjugated synthetic peptide derived from human Histone H1.2
- Isotype
- IgG
- Top Product
- Discover our top product SARS-CoV-2 N Anticorps primaire
-
-
- Indications d'application
- WB 1:300-5000
- Restrictions
- For Research Use only
-
- Concentration
- 1 μg/μL
- Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
- Agent conservateur
- ProClin
- Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C
- Stockage commentaire
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
- Antigène
- SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N)
- Autre désignation
- SARS-CoV-2 N (SARS-CoV-2 N Produits)
- Synonymes
- anticorps nucleocapsid phosphoprotein, anticorps N
- Sujet
- Optional[synonyms]: SARS-CoV-2 Nucleocapsid Protein, SARS-CoV-2 NP, nucleocapsid protein [Severe acute respiratory syndrome coronavirus 2], novel coronavirus N Protein, novel coronavirus Nucleocapsid Protein, 2019-nCoV Nucleoprotein, 2019-nCoV N, 2019nCoV N, 2019-nCoV N Protein, 2019 ncov N Protein, 2019-nCoV nucleocapsid protein.
-